Davin C Ashraf1, Oluwatobi O Idowu2, Qinyun Wang2, Tak YeEun2, Thomas S Copperman2, Sombat Tanaboonyawat3, Benjamin F Arnold4, Catherine E Oldenburg4, M Reza Vagefi2, Robert C Kersten2. 1. Department of Ophthalmology, University of California, San Francisco, San Francisco, California. Electronic address: davin.ashraf@ucsf.edu. 2. Department of Ophthalmology, University of California, San Francisco, San Francisco, California. 3. Department of Ophthalmology, University of California, San Francisco, San Francisco, California; Department of Ophthalmology, Phramongkutklao College of Medicine, Bangkok, Thailand. 4. Department of Ophthalmology, University of California, San Francisco, San Francisco, California; Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
Abstract
PURPOSE: The usefulness of topical antibiotic prophylaxis for routine oculofacial plastic surgery is not well established. Given concerns such as contact dermatitis, antibiotic resistance, and healthcare costs in conjunction with a low baseline rate of surgical site infections, the investigators sought to determine the frequency of infection with and without the use of topical antibiotic prophylaxis. DESIGN: Randomized, controlled, unmasked clinical trial. PARTICIPANTS: Adult patients undergoing routine periocular surgery without prior history of periocular surgical site infection, need for perioperative oral or parenteral antibiotics, or allergy to all study medications. METHODS: Participants were randomized before surgery to receive either antibiotic or placebo (mineral oil and petrolatum-based) ointment after surgery. Outcomes were measured at the first postoperative visit. The 2-tailed Fisher exact test was used to compare outcomes between groups. MAIN OUTCOME MEASURES: The primary outcome was the incidence of surgical site infections. The secondary outcomes included stratification of infections by patient risk characteristics, incidence of allergic contact dermatitis, and incidence of wound complications. RESULTS:Four hundred one participants were enrolled and randomized, and 13 participants did not proceed with surgery or were lost to follow-up. High-risk features for infection were identified in 24% of the placebo group and 21% of the antibiotic group. Surgical site infections were more common in the placebo group (2.7% vs. 0.0%; P = 0.025). The rate of contact dermatitis was similar (0.5% vs. 0.5%; P = 1.00), as was the rate of wound dehiscence (2.7% vs. 3.5%; P = 0.77). Among the placebo group, the incidence of infections in the low- and high-risk participants was 2.9% and 2.2%, respectively. Infections were treated with oral or topical antibiotics and resolved without complication, except in 1 patient who required 2 subsequent surgeries to address the sequelae. CONCLUSIONS: After routine oculofacial plastic surgery, patients treated with a topical antibiotic ointment showed a lower risk of surgical site infection compared with patients treated with a nonantibiotic ointment. Published by Elsevier Inc.
RCT Entities:
PURPOSE: The usefulness of topical antibiotic prophylaxis for routine oculofacial plastic surgery is not well established. Given concerns such as contact dermatitis, antibiotic resistance, and healthcare costs in conjunction with a low baseline rate of surgical site infections, the investigators sought to determine the frequency of infection with and without the use of topical antibiotic prophylaxis. DESIGN: Randomized, controlled, unmasked clinical trial. PARTICIPANTS: Adult patients undergoing routine periocular surgery without prior history of periocular surgical site infection, need for perioperative oral or parenteral antibiotics, or allergy to all study medications. METHODS:Participants were randomized before surgery to receive either antibiotic or placebo (mineral oil and petrolatum-based) ointment after surgery. Outcomes were measured at the first postoperative visit. The 2-tailed Fisher exact test was used to compare outcomes between groups. MAIN OUTCOME MEASURES: The primary outcome was the incidence of surgical site infections. The secondary outcomes included stratification of infections by patient risk characteristics, incidence of allergic contact dermatitis, and incidence of wound complications. RESULTS: Four hundred one participants were enrolled and randomized, and 13 participants did not proceed with surgery or were lost to follow-up. High-risk features for infection were identified in 24% of the placebo group and 21% of the antibiotic group. Surgical site infections were more common in the placebo group (2.7% vs. 0.0%; P = 0.025). The rate of contact dermatitis was similar (0.5% vs. 0.5%; P = 1.00), as was the rate of wound dehiscence (2.7% vs. 3.5%; P = 0.77). Among the placebo group, the incidence of infections in the low- and high-risk participants was 2.9% and 2.2%, respectively. Infections were treated with oral or topical antibiotics and resolved without complication, except in 1 patient who required 2 subsequent surgeries to address the sequelae. CONCLUSIONS: After routine oculofacial plastic surgery, patients treated with a topical antibiotic ointment showed a lower risk of surgical site infection compared with patients treated with a nonantibiotic ointment. Published by Elsevier Inc.
Authors: D P Smack; A C Harrington; C Dunn; R S Howard; A J Szkutnik; S J Krivda; J B Caldwell; W D James Journal: JAMA Date: 1996-09-25 Impact factor: 56.272
Authors: Susan R Carter; Jay M Stewart; Jemshed Khan; Kathleen F Archer; John B Holds; Stuart R Seiff; Roger A Dailey Journal: Ophthalmology Date: 2003-07 Impact factor: 12.079
Authors: J G Marks; D V Belsito; V A DeLeo; J F Fowler; A F Fransway; H I Maibach; C G Mathias; J R Nethercott; R L Rietschel; E F Sherertz; F J Storrs; J S Taylor Journal: J Am Acad Dermatol Date: 1998-06 Impact factor: 11.527
Authors: Clare F Heal; Jennifer L Banks; Phoebe D Lepper; Evangelos Kontopantelis; Mieke L van Driel Journal: Cochrane Database Syst Rev Date: 2016-11-07
Authors: Amer F Alsoudi; Lauren Ton; Davin C Ashraf; Oluwatobi O Idowu; Alan W Kong; Linyan Wang; Robert C Kersten; Bryan J Winn; Seanna R Grob; M Reza Vagefi Journal: Eye Contact Lens Date: 2022-04-01 Impact factor: 2.018